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Abstract
Tumor Endothelial Marker 8/Anthrax Toxin Receptor 1 (TEM8/ANTXR1) expression is induced in the vascular compartment
of multiple tumors and therefore, is a candidate molecule to target tumor therapies. This cell surface molecule mediates
anthrax toxin internalization, however, its physiological function in blood vessels remains largely unknown. We identified
the chicken chorioallantoic membrane (CAM) as a model system to study the endogenous function of TEM8 in blood vessels
as we found that TEM8 expression was induced transiently between day 10 and 12 of embryonic development, when the
vascular tree is undergoing final development and growth. We used the cell-binding component of anthrax toxin, Protective
Antigen (PA), to engage endogenous TEM8 receptors and evaluate the effects of PA-TEM8 complexes on vascular
development. PA applied at the time of highest TEM8 expression reduced vascular density and disrupted hierarchical
branching as revealed by quantitative morphometric analysis of the vascular tree after 48h. PA-dependent reduced
branching phenotype was partially mimicked by Wnt3a application and ameliorated by the Wnt antagonist, Dikkopf-1.
These results implicate TEM8 expression in endothelial cells in regulating the canonical Wnt signaling pathway at this day of
CAM development. Consistent with this model, PA increased beta catenin levels acutely in CAM blood vessels in vivo and in
TEM8 transfected primary human endothelial cells in vitro. TEM8 expression in Hek293 cells, which neither express
endogenous PA-binding receptors nor Wnt ligands, stabilized beta catenin levels and amplified beta catenin-dependent
transcriptional activity induced by Wnt3a. This agonistic function is supported by findings in the CAM, where the increase in
TEM8 expression from day 10 to day 12 and PA application correlated with Axin 2 induction, a universal reporter gene for
canonical Wnt signaling. We postulate that the developmentally controlled expression of TEM8 modulates endothelial cell
response to canonical Wnt signaling to regulate vessel patterning and density.
Citation: Verma K, Gu J, Werner E (2011) Tumor Endothelial Marker 8 Amplifies Canonical Wnt Signaling in Blood Vessels. PLoS ONE 6(8): e22334. doi:10.1371/
journal.pone.0022334
Editor: Masuko Ushio-Fukai, University of Illinois at Chicago, United States of America
Received March 12, 2011; Accepted June 23, 2011; Published August 1, 2011
Copyright:  2011 Verma et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grant number 1K22CA12736 from the Center to Reduce Cancer Health Disparities at the National Cancer Institute/National
Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: ewerner@emory.edu
Materials and Methods
Reagents and cell lines
Human recombinant VEGF165, recombinant mouse Wnt3a and
DKK-1 (R&D Systems), DQ-PA and FITC-labeled PA (List Biological
Laboratories). Hek293 cells (QB-293) were obtained from Qbiogene.
Qualitative RT-PCR
Total RNA (1 mg) purified from CAM and liver extracted at the
indicated day of development, was used to reverse transcribe
mRNA with oligoT using AccuScript (Promega). PCR to detect
gene expression was performed using 100 ng cDNA as a template
and optimized at 40 cycles and annealing at 48uC. The bands
were quantified by densitometry using ImageJ analysis software.
The identity of all PCR products was confirmed by sequencing.
The forward and reverse primer pairs (59 to 39) used were: TEM8
(XM_425758.2) tgagagggaggccaatcggtca and gcagcggcccttgtctcctg;
CMG2 (XM_420539) gcagattgagaagcagggag and tgcatgactgctt-
caacac; GAPDH (NM_204305) ggagtcaacggatttggcc and
gtcacgctcctggaagatag; VE cadherin (NM_204227.1) atctcaga-
caacggcaatcc, and gaccgctcagatccttcttg; Axin-2 (NM_204491.1)
tgccccgcggaggaatgag and ctctgacgcccgccgtaac.
Eggs and CAM preparation
Fertilized Leghorn chicken eggs were obtained from a local
provider and kept in a 37uC, 60% humidity incubator for 7
days. The CAM was dropped and the window sealed with
stretchy tape (Scotchgard, 3M). At the day of the experiment,
3M filter paper squares with a 0.8 cm diameter hole were
sterilized by soaking in 70% ethanol, air-dried in a sterile air
cabinet, soaked in 2.5 mg/ml cortisone acetate in 95% ethanol
to prevent an inflammatory response to the filter and placed on
the CAM. Proteins and growth factors were diluted in 15 mL
avian Ringer solution and delivered in the center of the hole.
After 2 days, the filters were fixed in ovo with 4% paraformal-
dehyde in PBS and dissected. The filters showing surrounding
blood vessels of normal appearance, were photographed using a
Stemi SV6 stereomicroscope (Zeiss) equipped with a Digital
Photo color camera DFC 500 (Leica).
In situ hybridization
Filters were placed on the CAM at day 10 and fixed for 20 min
in ovo at day 11 with 4%PFA. The filters were excised, bleached for
1 h with 0.3% H2O2 and treated with 5 mg/ml proteinase K in
PBS for 5 min at room temperature.
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were generated using Riboprobe in vitro transcription kit
(Promega), using as a template the PCR product cloned in pCII
vector (Invitrogen). CAM were treated with 0.1 M Triethanol-
amine pH 7.5, and dehydrated in ethanol series (%50, %75, %95).
After hydrated, they were pre-hybridized at 55uC for 1 hour in
0.3 M NaCl, 20 M Tris-HCl pH 8, 5 mM EDTA, 1x Denhardt’s
reagent, 1% Sarcosyl, 50% formamide 10% dextran sulfate,
0.25 mg/ml yeast tRNA (Sigma). Probes were denatured at 80uC
for 5 minutes, chilled in ice and diluted in hybridization buffer.
CAM were hybridized with their probes (200 mL each) for 16 to
20 hours at 55uC. To remove nonspecifically bound probes, CAM
were washed in 2x SSC, 0.5x SSC at 56uC. Hybridization signals
were visualized with antidigoxigenin antibody–alkaline phospha-
tase conjugates using 5-bromo-4-chloro-3-indoylphosphate and
nitro-blue tetrazolium as chromogens (Boheringer Manheim).
Morphometric analysis of Angiogenesis
For morphological analysis, the pictures were converted into
binary images using ImageJ after converting to 8-bit grayscale,
two-fold background subtraction with a rolling ball of 50 and 20
radius respectively and contrast/brightness adjustments as neces-
sary. The binary images were analyzed using AngioQuant
software, an automated image analysis tool developed to quantify
in vitro angiogenesis assays by measuring number of tubules
complexes, their size, length and number of branching points [1].
TEM8 expression in HMEC
Primary Human Microvascular Endothelial cells were provided
by Dr. Kowalczyk and cultured in EBM-2 (Lonza). A confluent
monolayer was infected using a recombinant adenovirus to
overexpress HA-tagged TEM8 or GFP (control) [40]. After 18h,
the monolayer was incubated with or without 1 mg/ml PA for 3h
and analyzed by western blot using anti active beta catenin (ABC,
clone 8E7), HA tag, anti pan-beta catenin and tubulin antibodies
(Sigma).
Whole mount immunofluorescence
Filters were fixed in ovo with 4%PFA for 20 min. After excision,
they were blocked for 2 h in 1% BSA, 0.1% Triton-X100 in PBS.
Primary antibodies for FITC (Invitrogen), smooth muscle alpha
actin and beta catenin (Sigma) or avß3 integrin (Millipore) were
incubated overnight at 4uC. After washes in BSA-TX100, Alexa
conjugated secondary antibodies were incubated at 1:1000
dilution in BSA-TX100 overnight at 4uC. The filters were
embedded in gelvatol for imaging using a confocal microscope
equipped with 488 nm Argon and 568 nm HeNe lasers (LSM510;
Carl Zeiss). Images were acquired at 2048x2048 pixel resolution,
without gamma adjustment and at 8-bit depth at identical
conditions for all samples in the same experiment. Brightness
and contrast was adjusted to all images after assembling the figure
panels.
Nuclear/cytoplasmic ratio of beta catenin levels
To measure relative levels of beta catenin, a line was traced
along the longitudinal axis of the cell nucleus on unprocessed LSM
images of beta catenin staining using the line tool of Methamorph
software. The intensity of each pixel in the line was recorded using
the linescan measurement tool and compared to the pixel intensity
when the line was placed on the cytosol area of lowest staining in
the same cell. Thus, this ratio is independent of intercellular
variability in background staining as well as variations in relative
TEM8 and beta catenin expression levels.
TCF/LEF Reporter Gene Assay
Wild-type and TEM8 expressing Hek293 cells were seeded on
35 mm dishes and transfected using Lipofectamine 2000
(Invitrogen) and 4 mg/ml of reporter plasmid (M50 Super 8x
TOPFlash, obtained via Addgene from Dr. Randall Moon [2]).
After 24 h, the transfected cells were seeded on 96 well plates and
treated with or without recombinant mouse Wnt3a and/or PA at
the indicated concentrations. Cells were lysed 18h later using
Steady-Glo reporter substrate and lysis buffer (Promega) and
luciferase activity was measured with a SynergyHT plate reader
(BioTek). Cell number was corrected by protein concentration.
Statistics
For statistical analyses, a non-paired student t test assuming
equal variance was applied. A probability value of less than 0.05
was considered significant. The n values refer to replicates from
separate animals or independently generated cell lines. When
more than 2 samples were compared, a Student-Newman-Keuls
Multiple Comparison test was applied.
Introduction
TEM8 is an integrin-like membrane protein that is highly
expressed in endothelial cells lining blood vessels in colon tumors
[3]. Subsequent studies have shown that while this molecule is
expressed at low levels in normal tissues, it is induced in the
vascular compartment of multiple primary tumors and metasta-
ses, but not during normal vascularization occurring during
wound healing or corpus luteum formation [4,5]. This distinct
expression pattern poises TEM8 as a candidate molecule to
selectively target tumor-associated vasculature. In pre-clinical
studies, fusion molecules between a receptor binding protein and
a toxic enzymatic moiety, show potent anti-tumor and anti-
vascular effects [6,7]. The design, testing, and use of TEM8-
directed therapies would benefit from further mechanistic
knowledge about TEM8 function in endothelial cells and in
blood vessels [8]. Furthermore, TEM8 function could reveal
novel properties of tumor-associated blood vessels. However, the
physiological function of TEM8 in the vascular compartment
remains unknown.
TEM8 shares extensive structural and functional homology with
Capillary Morphogenetic molecule 2 (CMG2), which is more
widely expressed in the organism and is induced during in vitro
capillary morphogenesis in collagen gels [9]. Both cell surface
molecules bind the cell-binding component of the anthrax toxin,
Protective Antigen (PA), which mediates toxin complex internal-
ization and facilitates release of the enzymatic components, lethal
and edema factors, into the host cell cytosol (reviewed in [10]). A
potential role of anthrax toxin receptors in vascular physiology is
further highlighted by the characteristic alteration of vascular
function in anthrax pathophysiology. In fact, vascular damage can
be replicated by injecting the tripartite holotoxin into the blood
stream of animal models [11,12]. The holotoxin also disrupts
vascular morphogenesis in zebrafish and retinal development in
mice [13,14]. Moreover, Anthrax toxin binding to TEM8/CMG2
has been exploited in preclinical studies to deliver fusion proteins
to tumors and tumor associated blood vessels [15]. In most cases,
however, endothelial cells express both receptors, where they are
involved in cell proliferation, migration and promoting angiogen-
esis in vitro and in vivo ([16,17,18,19] and our unpublished
results). These observations have provided a limited understanding
of TEM8-specific function in the vasculature since toxin-mediated
cell binding is the defining mechanism affecting the vasculature in
the aforementioned studies.
TEM8 Regulates Wnt Signaling
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chorioallantoic membrane, as a suitable model to study TEM8-
specific mechanisms in vascular development and physiology,
because TEM8 expression is transiently induced in the absence of
detectable levels of CMG2. CAM development recapitulates
several phylogenetically conserved mechanisms for blood vessel
formation. New vessels form by sprouting angiogenesis from pre-
existing vessels, by in situ differentiation of precursor cells
(vasculogenesis), and by intussusceptive microvascular growth.
These vascular morphogenetic processes are observed in normal
and pathological blood vessel generation in mammals and are
regulated by highly conserved mechanism and molecules [20].
The dynamic nature of the vascular plexus in the CAM is
illustrated by its capacity to vascularize grafted organs, tumor
tissue, and tumor cells, reproducing some of the processes
occurring during early tumor-induced angiogenesis. Furthermore,
as we show in the current work, the semi-planar arrangement of
blood vessels developing in a regular hierarchical pattern, makes
this system amenable for quantitative morphometric analysis of
blood vessel formation.
We found that TEM8 is selectively and transiently induced in
the CAM during a discrete developmental stage of vascular
morphogenesis, correlating with intussusceptive angiogenesis.
Consistent with a functional role of TEM8 receptors at this stage,
TEM8 engagement by PA led to PA accumulation in endothelial
cells. Moreover, PA-TEM8 complexes disrupted blood vessel
morphogenesis, reducing the number of branching events and first
order blood vessels. These phenotypes were partially mimicked by
Wnt3a and were reverted by the Wnt antagonist, Dikkopf-1. We
propose that developmentally controlled expression of TEM8
regulates vessel patterning and density by fine-tuning canonical
Wnt signaling.
Results
TEM8 is induced in the vascular compartment during
chick chorioallantoic membrane development
We hypothesized that if TEM8 plays specific roles in normal
vascular development, then its expression should be restricted
spatially to the vascular compartment of an organ and temporally
to events modulated by this receptor. To test these predictions, we
selected the chick chorioallantoic membrane, an organ possessing
a hierarchical vascular development. CAM forms at day 5 of
embryonic development when the chorionic ectoderm fuses with
the allantoic endoderm. The membrane grows and expands until
day 7 by endothelial cell proliferation and capillary sprout invasion
of the mesenchyme to form a capillary plexus. Between days 8 and
12, blood vessels form by remodeling of the capillary plexus by
intussusceptive angiogenesis until the CAM reaches a mature
organization by day 12 [21]. To determine whether TEM8 is
expressed in CAM blood vessels, we used RT-PCR to evaluate the
expression of TEM8 and CMG2. We found that while TEM8 is
expressed at low levels at early stages of CAM development and in
the mature CAM (after day 12), there is a transient increase in
expression that peaks between days 10 and 12 (Fig. 1A). In
contrast, VE-cadherin expression, a marker for endothelial cells,
showed a sustained increase during this period, consistent with
continuous expansion of the vascular compartment (Fig. 1B).
Interestingly, CMG2 mRNA expression was undetectable in the
CAM until day 12 (Fig. 1A). To exclude differential sensitivity in
receptor detection by RT-PCR, we analyzed TEM8 and CMG2
expression in the embryonic chicken liver at day 11. CMG2 was
the predominant anthrax toxin receptor expressed in liver in
contrast to TEM8, which was expressed at very low levels (Fig. 1C).
These results show a differential expression of anthrax toxin
receptors in the CAM and a brief temporal window when TEM8
expression is induced. These data suggest TEM8 participation in
CAM morphogenesis in a temporally restricted developmental
process.
We asked next whether TEM8 expression is associated with the
CAM vascular compartment. We used a two-pronged approach to
determine the cellular compartment expressing TEM8. First, we
generated antisense and sense cDNA probes labeled with
digoxygenin-nucleotides to use in whole-mount in situ hybridiza-
tion of CAM at day 11. Secondly, we used fluorescently labeled
recombinant PA to identify the cellular compartment expressing
anthrax toxin receptors. CAM hybridization with an anti-sense
probe generated a signal specifically associated to blood vessels
and the capillary plexus (Fig. 2B). The staining was heterogeneous,
but continuous throughout the small caliber vascular compart-
ment. In contrast, a sense probe (Fig. 2A) or no probe (Fig. 2C)
produced negligible signal even though samples were processed
under identical conditions. Next, we used FITC labeled recom-
binant PA to identify PA-binding structures or cells in the CAM.
FITC-PA was detected by indirect immunofluorescence using an
anti-FITC antibody. We incubated day 11 CAM with FITC-PA in
vitro for 2h at 22uC in order to allow for intracellular
accumulation of the labeled ligand due to recycling activity of
the receptor [22]. As shown in Fig. 3, incubation at 22uC increases
dramatically the sensitivity of the detection when compared to
incubation at 4uC, an observation consistent with receptor-
mediated endocytosis. FITC-PA binding was specific, because a
10-fold excess of non-labeled PA reduced the signal. We attribute
incomplete competition by cold ligand to the mechanism for PA
internalization, which requires the oligomerization of seven PA
molecules [10]. FITC-PA was concentrated in fully formed blood
vessels, in cells with a cobblestone appearance characteristic of
endothelial cells. Co-staining with antibodies for cell-specific
markers showed that PA accumulated mostly in avß3 positive
cells, a marker previously shown to identify endothelial cells in the
chicken CAM (Fig. 3B) [23]. In contrast, no co-localization was
observed with anti smooth muscle actin, a marker for pericytes,
which do not cover blood vessels completely at this day of CAM
development [24]. In situ hybridization and immunodetection of
Figure 1. TEM8 expression is induced during chicken CAM
development. A RT-PCR analysis of TEM8 expression over time. cDNA
was prepared at the indicated day of development from total RNA
isolated from CAM. Samples were standarized by GAPDH expression
and analyzed with primers for TEM8, CMG2, VE-cadherin. B Average
Ratio (+/2SEM) of TEM8 or VE-cadherin over GAPDH of 4–5 eggs
collected at the indicated time of development. C Analysis of TEM8 and
CMG2 expression by RT-PCR in CAM and liver at day 11 of development.
doi:10.1371/journal.pone.0022334.g001
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the most prominent structures expressing TEM8 at day 11 of
CAM development. These results indicate that endothelial cells
express functional TEM8 receptors.
TEM8 receptor engagement with the ligand Protective
Antigen (PA) reduces branching morphogenesis and
blood vessel density, similar to canonical Wnt pathway
activation
TEM8 expression analysis (Fig. 1) indicates that TEM8 is the
major anthrax toxin receptor expressed in the CAM. Thus, PA
can be used as a tool to either engage TEM8 activity or disrupt
normal function by inducing receptor internalization and
degradation [22,25]. We took advantage of the accessibility of
the CAM capillary plexus to exogenous agents to test whether PA
binding to TEM8 modified CAM vasculogenesis or blood vessel
function. We performed these experiments at day 11, 24 hours
before the peak of TEM8 expression. PA application at day 11
decreased the caliber of blood vessels after 48 hours, which
exhibited a pattern of reduced complexity and hierarchical
branching (Fig. 4A). PA induced frequent blood vessel disconti-
nuities (arrowheads) and disappearance of first order pre-capillary
vessels (averaging 30 mm diameter), which is reflected in a reduced
number of branches (Fig. 4B)[26]. In contrast, when 100 ng
VEGF165 was applied on the CAM for 48 h, the size of
complexes and number of branches increased without changes
in their patterning.
The planar and hierarchical arrangement adopted by the
newly formed CAM blood vessels is amenable to morphometric
analysis applying strategies and parameters used to describe
endothelial cell tubule formation in vitro. Therefore, we used
AngioQuant software to quantitatively describe PA-induced
changes in vessel branching, growth in length and diameter. To
exclude effects unrelated to receptor-ligand interactions, we
evaluated the effects of PA applied on CAM at day 9, when
TEM8 is expressed at low levels. The effects of PA applied at day
11 were also compared to the effects of VEGF, a pro-angiogenic
agent known to induce blood vessel growth and branching
[27,28]. The number of tubule complexes increased significantly
from 100.567.9 to 170.9615.9 (average 6 SEM) when PA was
applied at day 11, reflecting the increase in vessel discontinuities.
In contrast, VEGF reduced the number of complexes per area
from 83.364.2 to 25.264.9 (average 6 SEM), by promoting a
robust growth and expansion of complexes already existing at the
beginning of VEGF treatment. The reduced complexity and
number of primary branches in response to PA was reflected in a
reduction in the total length of tubule complexes and the mean
number of junctions from 161619 to 96.468.3 and from
1.1960.13 to 0.660.1, respectively. PA also reduced the mean
size of complexes from 1346.86264.8 to 615.2672.5, a
parameter describing both length and thickness of the blood
vessels. No significant differences were observed when PA was
applied at day 9, excluding effects by noxious contaminants
present in recombinant PA and highlighting a dependence on
TEM8 expression. Moreover, the effects of PA were abrogated by
PA denaturation at 70uC for 15 min before application on the
CAM and were transient, as branching and patterning recovered
by day 14 (not shown). These PA-induced CAM vascular
phenotypes are consistent with PA-TEM8 complexes preventing
Figure 2. TEM8 is expressed in the vascular compartment of
the CAM. In situ hybridization with sense A, anti-sense B or no probe
C of whole mount 11 day CAM preparations. Scale bar= 500 mm.
doi:10.1371/journal.pone.0022334.g002
Figure 3. Labeled PA accumulates in CAM blood vessels. A
Immunostaining for FITC label of day 11 CAM incubated for 2 h with
1 mg/ml FITC-PA at 22uC (a), with a 10 fold excess of unlabeled PA (b), at
4uC (c) or in the absence of PA (d). B Co-immunofluorescence for FITC
and alpha smooth muscle actin marker for pericytes or avß3 marker for
endothelial cells in day 11 CAM incubated for 2 h with 1 mg/ml FITC-PA
at 22uC. Scale bar= 50 mm.
doi:10.1371/journal.pone.0022334.g003
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formed pre-capillary vessels.
The phenotypic effects of PA on CAM blood vessels are
consistent with inhibition of branching events and/or reduced
stability of the blood vessels formed at day 11 and 12. Members of
the Wnt family have been implicated in blood vessel morphogen-
esis, remodeling and stabilization ([29,30] and reviewed in [31]).
Particularly, forced expression of beta catenin gain of function
mutant in endothelial cells leads to a strikingly similar phenotype
(see figure 2 in [32]). Wnt ligands bind to Frizzled receptors and
LRP5/6 co-receptors. Ligand binding to receptors induces beta
catenin stabilization by inhibiting GSK-3-dependent phosphory-
lation and thereby preventing beta-catenin targeting for protea-
somal degradation. Dephosphorylated beta catenin translocates to
the nucleus and relieves T-cell factor/lymphoid enhancer factor
(TCF/LCF) repression of gene transcription [33]. Furthermore,
additional reports link TEM8 to Wnt signaling: TEM8 interacts
with LRP6, a co-receptor for Wnt ligands, and causes beta catenin
stabilization in a cell line model system [34,35]. The phenotypic
similarities between PA-TEM8 effects in CAM and forced beta
catenin signaling in endothelial cells in vivo, lead us to test the
hypothesis that PA and/or TEM8 expression promotes Wnt beta-
catenin signaling in the chicken CAM. We tested first whether
exogenous Wnt application or pharmacological upregulation of
the pathway would trigger a vascular branching phenotype similar
to PA. Day 11 CAM was exposed to recombinant mouse Wnt3a,
which triggers the activation of the canonical pathway, or to LiCl,
which mimics Wnt pathway activation by inhibition of the GSK-
3ß kinase. Similar to PA, Wnt3a or the Wnt-mimic LiCl,
phenocopied the PA-induced branching pattern by reducing
branching events (Fig. 5A compare c & d to b and quantification
in Fig. 5C). Conversely, application of recombinant DKK-1
protein, an antagonist of endogenous Wnt binding to receptors
[36], increased the number of branches per vessel in both control
and PA treated CAMs (shown in Fig. 5B and quantified in Fig. 5C),
indicating that endogenous Wnt controls the number of branching
events during normal vasculogenesis. These results suggest that PA
up-regulates canonical Wnt signaling resulting in a reduction in
branch formation.
Increased TEM8 expression and PA stabilize beta catenin
pools in endothelial cells in vitro and in vivo
A hallmark for canonical Wnt signaling is the stabilization of
beta catenin intracellular pools. We predicted that if TEM8 up-
regulates Wnt signaling, then PA should stabilize beta catenin
levels in TEM8 expressing endothelial cells. We tested this
prediction both in vivo and in vitro using day 11 CAM and
primary cultured human endothelial cells. CAM were excised at
day 11 and incubated for 3h in the absence or presence of PA at
37uC followed by beta catenin staining. Beta catenin staining in
untreated CAMs was faint and distributed in an inconspicuous
pattern (Fig. 6A). Upon PA treatment, beta catenin overall
staining intensity increased and localized to cell-cell junctions,
most notable in first order vessels. The effects of PA in vivo were
recapitulated in vitro, in primary cultured human microvascular
endothelial cells. PA addition to endothelial cells expressing
recombinant TEM8 induced significant beta catenin accumu-
lation as determined by immunoblot (Fig. 6B) and at cell-cell
junctions as visualized by immunofluorescence (Fig. 6D). The
magnitude of beta catenin accumulation was comparable to the
addition of recombinant Wnt3a to non-infected cells (Fig. 6B).
Albeit not statistically significant, recombinant TEM8 expres-
sion alone was sufficient to increase beta catenin levels. We
attribute the high variability in beta catenin levels to the
presence of endogenous Wnt ligands, which are produced by
endothelial cells in culture [37] and the low sensitivity of the
assay for cells with abundant intercellular junctions [38].
Analysis for beta catenin translocation to the nucleus in
individual cells, revealed that TEM8 overexpression and PA
addition promoted beta catenin translocation to the nucleus as
revealed by an increased nucleo-cytoplasmic ratio of beta
catenin levels (Fig. 6C, and inserts in 6D). We sought further
evidence for beta catenin activation by using an antibody
specifically recognizing the dephosphorylated form of beta
catenin (anti Activated Beta Catenin) [39]. This antibody did
not yield a signal by immunofluoresence (not shown), but
detected a small pool of activated molecules in Wnt3a treated
endothelial cells and in PA treated TEM8-overexpressing
endothelial cells (Fig. S1). These results indicate that TEM8
overexpression and PA binding to TEM8 in endothelial cells
Figure 4. Protective Antigen disrupts blood vessel patterning
in the CAM. A Images of filters on CAM at day 13, after treatment at
day 11 with 1 mg PA, without agent or at day 9 with 100ng VEGF.
Morphometric analysis of these filters with AngioQuant yields average
values shown in (c). Scale bar=1 mm. B Selected areas from control
and PA-treated filters in (A) magnified to show details. Scale bar=
500 mm. Arrowheads point to a vessel discontinuity. C Average +/2
SEM of the indicated AngioQuant parameter after analysis at day 13
from eggs treated or not at day 9 (n=6) or day 11 (n=10) with 1 mgo f
PA, or with 100 ng VEGF at day 9 (n=6). *=p,0.05.
doi:10.1371/journal.pone.0022334.g004
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and in the nucleus, and a pool of beta catenin competent to
induce gene transcription.
TEM8 and its ligand PA positively regulate Wnt induced
gene transcription
An increased nucleo-cytoplasmic ratio of beta catenin levels by
TEM8-PA receptor-ligand complexes predicts a transcriptional
induction of canonical Wnt-responsive genes. We tested this
hypothesis by reconstituting TEM8- and PA-dependent beta
catenin phenotypes in Hek293 cells. This cell line does not express
endogenous anthrax toxin receptors and is responsive to Wnt
ligands activating the canonical pathway [38,40]. TEM8 expres-
sion was sufficient to increase basal and Wnt3a-induced levels of
beta catenin as determined by immunoblot in at least two
independently generated TEM8-expressing cell lines (Fig. 7A).
TEM8 conferred sensitivity to PA, which increased beta catenin
levels even further. We measured Wnt-dependent transcriptional
activation with a reporter plasmid containing multiple TCF
binding sites driving luciferase transcription (M50Super8xTOP
Flash). Wnt3a was sufficient to induce luciferase expression in wild
type cells (Fig. 7B) and TEM8 expression, although was not
sufficient to promote gene transcription by itself, amplified the
transcriptional response to Wnt3a, further increasing luciferase
expression from 14.164.6-fold in control cells to 32.465.7 SEM
in TEM8 expressing cells (Fig. 7B, average 6 SEM). Surprisingly,
PA equally reduced Hek293 cell response to Wnt3a irrespective of
whether these cells expressed or not TEM8 (to 73.668.2% TEM-
8 expressing cells and to 80.363.2% in control cells, n=4). This
TEM8-independent effect was also independent of PA concentra-
tion (not shown). Thus, we conclude that this is a receptor-
independent effect of PA in this cell type. We attribute the lack of
effect of PA on TCF transcriptional activation in Hek293 cells to a
cell specific response.
Positive modulation of Wnt transcriptional response by TEM8
in Hek293 cells predicts changes in the induction of Wnt-
responsive genes in the CAM associated to TEM8 expression and,
possibly, to PA application. To study Wnt-dependent gene
expression in vivo, the analyzed the mRNA levels by RT-PCR of
a universal reporter gene for canonical Wnt pathway activity,
Axin-2 [41]. Analysis of the same samples used in Fig. 1, showed
that axin-2 expression increased from day 8 to day 12 of CAM
development (Fig. 7C). In contrast to Hek293 cells, PA or Wnt3
application on CAM at day 10, increased Axin 2 expression as well
(Fig. 7D). Altogether, these results support the notion that TEM8
is a positive regulator of Wnt signaling and that PA binding
promotes this activity in endothelial cells in vitro and in the CAM
in vivo.
Discussion
We have defined a role for TEM8 in blood vessel morphogen-
esis acting as a modulator of Wnt-dependent vascular morphoge-
netic events. The highly stereotypic vascular development both in
time and spatial organization of the chicken CAM permitted
quantitative morphometric analysis of blood vessels in a nearly
bidimentional organ. In situ hybridization and functional staining
with labeled PA, indicate that in this organ, TEM8 is expressed in
endothelial cells in a narrow window of time that correlates with
organ vascularization by intussusceptive angiogenesis. At this
precise developmental time, TEM8 engagement with its ligand PA
alters blood vessel patterning and density affecting the hierarchical
architecture of the vascular tree reducing vessel branching. These
phenotypes are consistent with Wnt pathway activation.
TEM8 expression is up-regulated in CAM blood vessels
between days 10 and 12 of embryonic development. Temporal
expression of TEM8 coincides with a peak of intussusceptive
angiogenesis. In contrast to sprouting angiogenesis, intussusceptive
Figure 5. Morphological effects of PA are phenocopied or
ameliorated by regulators of the canonical Wnt pathway. Day 11
CAMs were incubated with agonist of the canonical pathway, wnt3a or LiCl
(A) or an antagonist DKK-1 (B) avian ringer solution (a,e), 1 mgP A( b , f , h ) ,
200 ng DKK-1 (g,h), 100 ng mWnt3a (c) or 5 mM LiCl (d) and photographed
after two days, at day 13 (Scale bar= 500 mm). CQuantitative analysis of the
mean number of branches per blood vessel complexes in the indicated
number of CAMs using AngioQuant. Error bars represent standard error.
doi:10.1371/journal.pone.0022334.g005
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without involving proliferation, cell matrix degradation and cell
migration [42]. This mechanism for vessel generation has been
detected in lung, kidney, and mammary gland development by
morphological criteria, because no biochemical markers have been
identified so far [43,44]. Intussusceptive angiogenesis is also found
in some tumors and increases during tumor revascularization after
radiation or anti-angiogenic therapy [45,46,47], and thus, is
proposed as an alternative mechanism for blood vessel formation
in tumor recurrences after therapy. An attractive possibility is that
TEM8 may play a role in normal and/or pathological
intussusceptive angiogenesis and may serve as a marker. However,
further studies are required to test whether TEM8 function is
directly linked to Intussusceptive angiogenesis.
Contrary to studies in endothelial cells in culture and in adult
tissues, where CMG2 seems to be expressed and have a
predominant role, we found that TEM8 is the predominant PA
receptor in the CAM. The selective expression of TEM8 is
Figure 6. Beta catenin levels and distribution in response to TEM8 and PA in endothelial cells. A Beta catenin immunostaining of day 11
CAM after in vitro incubation for 3 h at 37uC in the absence or presence of 1 mg/ml PA in DME. Scale bar= 50 mm. B Beta catenin levels detected by
western blot in lysates prepared from GFP- or TEM8-recombinant adenovirus infected HMEC treated with 100 ng/ml mWnt3a or 1 mg/ml PA for 3 h.
The intensity of the bands was corrected by tubulin levels and are relative to untreated control cells (n=4). C Relative beta catenin localization
expressed as nuclear/cytoplasmic ratio (see materials and methods) in control or TEM8- recombinant adenovirus infected HMEC, treated or not with
1 mg/ml PA for 3 h. The data was collected in 20 cells from 2 independent experiments. D Immunoflurescence staining for beta catenin distribution in
control and TEM8 expressing HMEC used to generate data shown in C. Size bar= 20 mm.
doi:10.1371/journal.pone.0022334.g006
Figure 7. TEM8 increases beta catenin dependent transcriptional activity in vitro and in vivo. A Beta catenin levels detected by western
blot in control and two independently generated TEM8-expressing HEK293 cell lines treated without or with 100 ng mWnt3a or 1 mg/ml PA for 3 h at
37uC. B Luciferase expression driven by a beta catenin responsive promoter (MF50 Super 8x TOPFlash) induced in control and TEM8 expressing
HEK293 cells by increasing concentrations of Wnt3a in the absence or presence of 1 mg/ml PA for 18 h. This is one representative experiment of 3.
Error bars are STDEV. C RT-PCR analysis for endogenous axin-2 expression in CAM at days 8 and 12 of development (+/2 SEM, n=3) D RT-PCR
analysis of endogenous axin-2 expression in CAM at day 12 after a 16h treatment with vehicle (control), 1 mg of PA or 100 ng mWnt3a.
doi:10.1371/journal.pone.0022334.g007
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expression in chick liver but not in the CAM at the time of the
experiments. Furthermore, the temporal course of TEM8
expression correlated with a time-restricted CAM response to
PA application. PA affected blood vessel patterning when applied
at the peak of TEM8 expression, but not when TEM8 was
expressed at low levels at day 9 (Fig. 4) or after day 12 (not shown).
These results not only point to a role for TEM8 expression, but
also support our conclusion that the effects induced by PA can be
unequivocally attributed to TEM8. Coincident with TEM8
mRNA peak expression, we observed that fluorescently labeled
PA accumulated in endothelial cells by a receptor-mediated
mechanism, supporting the expression of functional receptors in
this blood vessel compartment. PA applied to the CAM induced
changes in blood vessel branching hierarchy and density with a
reduction in primary vessels.
A reduced number in primary vessels and branching could
result from deficiencies in formation, stabilization of the newly
formed vessel or deregulated pruning. These processes would
preserve early hierarchical patterning and produce a phenotype
of apparent delayed or arrested development, while the observed
phenotype is consistent with growth following altered spatial cues.
Vascular density during blood vessel development is controlled by
the cooperative activity of temporally and spatially regulated
levels of Wnt and Notch to control tip cell activity and branch
stability. The PA-induced changes in vessel patterning that we
observed are strikingly similar to those resulting after expressing
gain-of-function beta catenin targeted to endothelial cells during
mouse development [32]. Paradoxically, a branching-deficient
phenotype results from beta catenin-induced transcription of a
ligand for Notch signaling, DLL4 [32]. DLL4 inhibits tip cell
activity and thereby blocks blood vessel branch development
[48,49]. Thus, super activation of beta catenin by PA binding to
TEM8 could lead to reduced branching by similar mechanism
acting at the tip cell. Further experiments are needed to test this
mechanism.
We propose that TEM8 modulates canonical Wnt signaling
during normal vascular development in the CAM and PA
functions as an agonist by engaging TEM8, further increasing
beta catenin activation. This model is supported by the following
findings: first, PA-induced morphological changes in the
vascularization pattern are replicated by Wnt3a incubation or
by treatment with LiCl, a non-selective Wnt pathway agonist.
Second, PA induced alterations were attenuated when Wnt
signaling was antagonized with DKK-1, which prevents endog-
enous Wnt from forming a complex with Frizzled and LRP5/6
[36]. DKK-1 also affected normal morphogenesis, increasing the
number of branching events, suggesting that canonical signaling
is necessary to determine branching events and blood vessel
density. Hyper branching phenotypes are observed as a result of
disruptive mutations in several components of the Wnt and Notch
pathways, including beta catenin loss-of-function, Notch defi-
ciency, and DLL4 Notch ligand inhibition [32,50]. Thus, DKK-1
effects on normal CAM and on the PA-induced phenotype
indicate that the canonical Wnt pathway becomes activated and
regulates vascular density at this stage of vascular development.
This model of TEM8-PA mediated Wnt signaling modulation is
further supported by PA induced axin-2 expression. Third, PA
affected a component of the canonical signaling pathway,
inducing beta catenin stabilization in endothelial cells in vivo
and in vitro as indicated by increased beta catenin staining at
endothelial cell junctions in the CAM in vivo, in HMEC in vitro,
and by western blot detection of protein levels. Although
increased beta catenin levels at junctions could mediate adhesive
functions, cadherins bind activated forms of beta catenin and this
pool is competent for transcriptional activation [38,51]. A role for
this larger pool of beta catenin in gene transcription is supported
by our findings of increased axin-2 expression in CAM
correlating with TEM8 expression at day 12, with axin-2
induction after PA or Wnt3a treatment and with TEM8
dependent amplification of Wnt3a-induced transcription in Hek
293 cells.
Previous studies have reported a direct interaction of TEM8
with LRP6 and regulation of LRP6 levels by TEM8 when
expressed in cell lines [34,35]. However, this interaction was
subsequently shown to be irrelevant for anthrax pathogenesis
[52,53]. Our findings provide a biological context where the
interaction of TEM8 with LRP6 might be relevant. In the
CAM, TEM8 and PA engagement could regulate the
availability and function of LRP6/5, favoring beta catenin
stabilization. Alternatively, TEM8 and PA could cooperate
with Wnt signal transduction pathway converging at regulating
either beta catenin phosphorylation, nuclear translocation,
and/or transcriptional activity. Our results predict that TEM8
expression in endothelial cells associated to tumor blood vessels
would increase the response of these cells to local Wnt
production by increasing the intracellular pools of beta catenin
available for signaling. Wnt activation in tumor endothelial
cells would confer similar growth and invasive properties as in
tumor cells.
Supporting Information
Figure S1 PA increases activated beta catenin levels in
TEM8 expressing HMEC. Activated Beta Catenin, Beta
catenin and tubulin levels detected by western blot in 5 mgo f
lysate prepared from control or TEM8-recombinant adenovirus
infected HMEC treated with 100 ng/ml mWnt3a or 1 mg/ml PA
for 3 h. One of 2 experiments yielding similar results is shown.
(TIF)
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